Preventing respiratory syncytial virus in homebound premature infants

Home Healthcare Nurse

Volumn 25, Issue 7, 2007, Pages 429-432

  Austin, Jennifer ^a  

^a Woman's Home Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; MONOCLONAL ANTIBODY; PALIVIZUMAB;

COMMUNITY HEALTH NURSING; DISEASE TRANSMISSION; EDUCATION; HAND WASHING; HOME CARE; HOMEBOUND PATIENT; HOSPITALIZATION; HUMAN; HUMAN RELATION; INDOOR AIR POLLUTION; INFECTION CONTROL; NEWBORN; NURSE ATTITUDE; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; PARENT; PATIENT; PATIENT CARE PLANNING; PATIENT SELECTION; PREMATURITY; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; STATISTICS; TRUST; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; COMMUNITY HEALTH NURSING; HANDWASHING; HOME CARE SERVICES; HOMEBOUND PERSONS; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFECTION CONTROL; NURSE'S ROLE; NURSING ASSESSMENT; PARENTS; PATIENT CARE PLANNING; PATIENT SELECTION; PROFESSIONAL-FAMILY RELATIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS; TOBACCO SMOKE POLLUTION; TRUST; VISITORS TO PATIENTS;

EID: 34547629190     PISSN: 0884741X     EISSN: 15390713     Source Type: Journal    
DOI: 10.1097/01.NHH.0000281609.58553.7f     Document Type: Conference Paper

References (10)

1. American Academy of Pediatrics. (2003). Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics, 112(6), 1442-1446.
2. Banning, M. (2006). Respiratory syncytial virus: Disease, development, and treatment. British Journal of Nursing, 15(14), 751-755.
3. Bracht, M., Heffer, M., & O'Brien, K. (2005). Preventing respiratory syncytial virus (RSV) infection. Advances in Neonatal Care, 5(1), 50-51.
4. Centers for Disease Control and Prevention. (2006, October 10). Respiratory syncytial virus trends. Retrieved October 17, 2006 from http://www.cdc.gov/ncidod/dvrd/revb/nrevss/rsvtrel.htm
5. Groothuis, J. R., & Nishida, H. (2002). Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab). Pediatrics International, 44, 235-241.
6. Lauts, N. M. (2005). RSV: Protecting the littlest patients. RN, 68(12), 46-52.
7. Leidy, N. K., Margolis, M. K., Marcin, J. P., Flynn, J. A., Frankel, L. R., Johnson, S., et al. (2005). The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery. Pediatrics, 115(6), 1536-1546.
8. MedImmune, Inc. (2004). Synagis TM (palivizumab) liquid solution Q & A. Gaithersburg, MD: Author.
9. Pruitt, B. (2005). Keeping respiratory syncytial virus at bay. Nursing 2005, 35(11), 62-64.
10. Zarbock, S. F. (2000). RSV prophylaxis: Building the case for home care. Home Care Provider, June, 90-91.